| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 30, 2006
Accepted on September 5, 2006
Division of Pediatric Endocrinology, Stanford University, Stanford, CA; Division of Pediatric Endocrinology, University of North Carolina at Chapel Hill, NC; US Medical Division (Endocrinology), Lilly Research Laboratories, Indianapolis, IN; Division of Endocrinology, Thomas Jefferson University, Philadelphia, PA; Children's Hospital and Regional Medical Center, University of Washington School of Medicine, Seattle, WA; Division of Pediatric Endocrinology, Riley Hospital for Children, Indiana University, Indianapolis, IN; Children's Mercy Hospital, Kansas City, MO
* To whom correspondence should be addressed. E-mail: pfechner{at}stanford.edu.
Context: Little information exists regarding FSH values in very young girls with Turner syndrome (TS).
Objectives: To evaluate the pattern, natural progression and karyotype-related differences in FSH secretion in young, prepubertal girls with TS.
Study Design: FSH was measured at study entry and annually for 2 yr.
Setting: "Toddler Turner" study conducted at 11 US pediatric endocrine centers.
Study Participants: 88 girls with karyotype-proven TS aged 9 months to 4 yr.
Main Outcome Measures: By-karyotype differences in FSH concentration; age-related changes in FSH.
Results: Mean (±SD) FSH was markedly elevated in the 45,X (n = 56: 68.3 ± 36.0 IU/L) and Other groups (n = 15 [excluding 3 subjects with Y-containing karyotypes]: 52.7 ± 50.8 IU/L) but was minimally elevated in girls with 45,X/46,XX mosaicism (n = 14: 10.1 ± 13.5 IU/L, P < 0.005 both comparisons). Over the 2-year period, FSH declined in the 45,X group (-13.4 IU/L/yr, P < 0.0001). Nonetheless, only 3 of 159 FSH values fell within normal range for age at any time during the 2-year study. FSH decline was similar in the Other group (-14.3 IU/L/yr, P = 0.0032). In contrast, no significant decrease in FSH with age was observed in the 45,X/46,XX group.
Conclusions: In contrast to the original report of FSH concentrations in individuals with TS (Conte FA et al. 1975, J Clin Endocrinol Metab 40:670-674), this study demonstrates distinct differences in patterns of FSH secretion between young girls with monosomy TS, who have persistent elevation of FSH to age 6, and those with 45,X/46,XX mosaicism, whose FSH values suggest retained ovarian function in the majority. These findings have implications for patient management and family counseling.
This article has been cited by other articles:
![]() |
M. L. Davenport, B. J. Crowe, S. H. Travers, K. Rubin, J. L. Ross, P. Y. Fechner, D. F. Gunther, C. Liu, M. E. Geffner, K. Thrailkill, et al. Growth Hormone Treatment of Early Growth Failure in Toddlers with Turner Syndrome: A Randomized, Controlled, Multicenter Trial J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3406 - 3416. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |